Advertisement
News
Subscribe to MDT Magazine News

Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®

April 21, 2011 10:36 am | by Bio-Medicine.Org | Comments

ST. LOUIS, April 21, 2011 / PRNewswire/ -- Fleming Pharmaceuticals, maker of ThyroShield®– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to...

TOPICS:

Facebook Page on Low Body Temperature Offers Free Coupon Codes to Fans

April 21, 2011 10:32 am | by Bio-Medicine.Org | Comments

LADY LAKE, Fla., April 21, 2011 /- Dr. Denis Wilson's Facebook page on Wilson's Temperature Syndrome has recently started offering coupon codes to their fans. These coupon codes entitle them to free shipping of the products available on the wilsonssyndrome.com website. Wilson's...

TOPICS:

Summary Box: UnitedHealth 1Q profit climbs 13 pct

April 21, 2011 9:45 am | by The Associated Press | Comments

QUARTERLY GROWTH: UnitedHealth Group Inc. said Thursday it earned $1.35 billion, or $1.22 per share, in the first quarter. That's up from $1.19 billion, or $1.03 per share, in the same quarter last year. Revenue rose 10 percent to $25.43 billion.WALL STREET EXPECTATIONS: Analysts surveyed by...

Advertisement

Massachusetts, South Korea heat up ties in life sciences

April 21, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Massachusetts and South Korean government officials met this week seeking to deepen collaborations in life sciences, high tech and other areas, including signing a three-year memorandum of understanding. A second meeting, which included Boston-based Oxford Bioscience Partners, which...

InfraReDx gets European CE approval for coronary imaging system

April 21, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

InfraReDx Inc. of Burlington has received CE mark approval in Europe to start commercializing its LipiScan IVUS Coronary Imaging System. The company received 510(k) medical device clearance from the U.S. Food and Drug Administration for the product in 2010.

iMD Companies, Inc. Acquires OMI LLC and Files Financials for 2010(2)

April 21, 2011 8:37 am | by Bio-Medicine.Org | Comments

TAMPA, Fla., April 21, 2011 /- iMD Companies (ICBU.PK) is pleased to announce that is has acquired an Independent Diagnostic Testing Facility (IDTF), Optimum Mobile Imaging LLC, which increases and diversifies the Company's portfolio of Medical Service businesses.  The acquisition...

TOPICS:

Scott & White Healthcare Broadcasts Live Surgery to Sao Paolo, Brazil

April 21, 2011 8:35 am | by Bio-Medicine.Org | Comments

TEMPLE, Texas, April 21, 2011 /- Scott & White Healthcare today teleconferenced one of the world's first live international surgical procedures to repair an abdominal aortic aneurysm to conference attendees in Sao Paolo, Brazil. The meeting, CICE (Current Issues in Comparative...

TOPICS:

FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, April 21, 2011 /- Nektar Therapeutics (Nasdaq: NKTR ) today announced that the company's oncology drug candidate, NKTR-102, has been granted orphan drug status for the treatment of women with ovarian cancer by the U.S. Food and Drug Administration (FDA). "This designation...

TOPICS:
Advertisement

New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., April 21, 2011 /- Masimo (NASDAQ: MASI ) announced today that a new study published in this month's issue of the peer-reviewed journal, Annals of Emergency Medicine, demonstrates that noninvasive Masimo carboxyhemoglobin (SpCO®) measurements provide an "effective...

TOPICS:

Caliper Life Sciences to Present at the 36th Annual Deutsche Bank Health Care Conference

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

HOPKINTON, Mass., April 21, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that Kevin Hrusovsky, Caliper's President and CEO, will present at the 36th Annual Deutsche Bank Health Care Conference in Boston on May 2, 2011 at 10:40 a.m. ET. A live webcast of the...

TOPICS:

iMD Companies, Inc. Acquires OMI LLC and Files Financials for 2010

April 21, 2011 8:33 am | Comments

TAMPA, Fla., April 21, 2011 /- iMD Companies (ICBU.PK) is pleased to announce that is has acquired an Independent Diagnostic Testing Facility (IDTF), Optimum Mobile Imaging LLC, which increases and diversifies the Company's portfolio of Medical Service businesses.  The acquisition...

Cepheid swings to profit in 1st quarter

April 21, 2011 7:45 am | by The Associated Press | Comments

Shares of molecular diagnostics company Cepheid were flat Thursday despite stronger-than-expected quarterly results.THE SPARK: The Sunnyvale, Calif., company reported a profit of $527,000, or a penny per share, in the first quarter of 2011. A year ago Cepheid took a loss of $4.3 million, or 7...

Baxter International reports 1Q profit

April 21, 2011 7:45 am | by The Associated Press | Comments

Drug and medical device maker Baxter International Inc. on Thursday reported a profit in the first quarter on a mix of higher sales and lower costs, and the company boosted its full-year financial outlook.The company earned $577 million, or 98 cents per share, compared with a loss of $60...

Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder

April 21, 2011 6:35 am | by Bio-Medicine.Org | Comments

BRANFORD, Conn., April 21, 2011 /- Marinus Pharmaceuticals, Inc., the leader in the development of neurosteroids for central nervous system disorders, today announced commencement of a proof-of-concept clinical trial of its lead candidate ganaxolone for the treatment of posttraumatic...

TOPICS:

Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association

April 21, 2011 6:35 am | by Bio-Medicine.Org | Comments

RENO, Nev., April 21, 2011 /- Sanare, LLC, a leading provider of care management solutions for people with diabetes, and its new consumer brand, BrightSky, have become National Strategic Partners of the American Diabetes Association.® (Logo:...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading